The laboratory investigation, management, and infection prevention and control of Candida auris: a narrative review to inform the 2024 national guidance update in England
2024/05/21 by Christopher R. Jones, Claire Neill, Andrew M. Borman +18 · 23 citations
Medicine · Immunology and Microbiology · #Antifungal resistance and susceptibility #Antibiotic Use and Resistance #Fungal Infections and Studies
paper · doi:10.1099/jmm.0.001820
Abstract
The emergent fungal pathogen Candida auris is increasingly recognised as an important cause of healthcare-associated infections globally. It is highly transmissible, adaptable, and persistent, resulting in an organism with significant outbreak potential that risks devastating consequences. Progress in the ability to identify C. auris in clinical specimens is encouraging, but laboratory diagnostic capacity and surveillance systems are lacking in many countries. Intrinsic resistance to commonly used antifungals, combined with the ability to rapidly acquire resistance to therapy, substantially restricts treatment options and novel agents are desperately needed. Despite this, outbreaks can be interrupted, and mortality avoided or minimised, through the application of rigorous infection prevention and control measures with an increasing evidence base. This review provides an update on epidemiology, the impact of the COVID-19 pandemic, risk factors, identification and typing, resistance profiles, treatment, detection of colonisation, and infection prevention and control measures for C. auris . This review has informed a planned 2024 update to the United Kingdom Health Security Agency (UKHSA) guidance on the laboratory investigation, management, and infection prevention and control of Candida auris . A multidisciplinary response is needed to control C. auris transmission in a healthcare setting and should emphasise outbreak preparedness and response, rapid contact tracing and isolation or cohorting of patients and staff, strict hand hygiene and other infection prevention and control measures, dedicated or single-use equipment, appropriate disinfection, and effective communication concerning patient transfers and discharge.
Cited by
- Comprehensive Review of Candidozyma (Candida) auris Management: Insights From the Society of Infectious Diseases Pharmacists
- Enhancing ICU Candida spp. surveillance: a cost-effective approach focused on Candida auris detection. [europepmc]
- Cerebrospinal Drain Infection by Candida auris : A Case Report and Review of the Literature. [europepmc]
- Changing trends in the sources and volumes of clinical cultures with Candida auris at an integrated health system in Miami, Florida, United States, 2019-2023. [europepmc]
- Candida auris : A Continuing Threat. [europepmc]
- A Comprehensive Review of Candidemia and Invasive Candidiasis in Adults: Focus on the Emerging Multidrug-Resistant Fungus Candida auris . [europepmc]
- Risk Factors for Candidozyma auris Among Admitted Patients in Riyadh, Saudi Arabia (2020-2022). [europepmc]
- Diagnostic Approaches for Candida auris : A Comprehensive Review of Screening, Identification, and Susceptibility Testing. [europepmc]
- Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives. [europepmc]
- Name changes for fungi of medical importance, 2022-2024. [europepmc]
- Consensus paper on Candida auris by Türkiye EKMUD, ID-IRI, THSK of Ministry of Health of the Republic of Türkiye, KLIMUD, TMC, TARD, and TYBD. [europepmc]
- Genetic and environmental control of parasexual reproduction in the pathogenic Candida species. [europepmc]
- The rising challenge of Candida auris : insights into its transmission, drug resistance, and infection control strategies. [europepmc]
- Analysis of Candida auris resistance and associated risk factors in hospitalized patients at a tertiary care hospital in China. [europepmc]
- Evaluation of a novel PCR-based assay for the detection of Candida auris colonization. [europepmc]
- Candidozyma auris Reported in Scotland: a Call for Vigilance Amid Global Rise. [europepmc]
- Microbe Profile: Candidozyma auris: an emergent and resilient yeast and new antifungal strategies. [europepmc]
- Candida auris Urinary Tract Colonization and Nosocomial Infection Control Strategies in Shanghai. [europepmc]
- Development of a Loop-Mediated Isothermal Amplification (LAMP) for the screening of Candida auris. [europepmc]
- Candidozyma auris and the Perfect Storm of Fungal Pathogenicity: Adaptation, Persistence, and Resistance. [europepmc]
- Epidemiology, Distribution, Key Characteristics, and Challenges of Candidozyma auris (Formerly Candida auris): A Narrative Review With a Special Focus on Türkiye. [europepmc]
- Recent Outbreaks, Resistance Trends, and Control Measures in Candida auris and Candida glabrata Infections. [europepmc]
- Candida species identified by MALDI-TOF and antifungal susceptibility in hospitalized patients with COVID-19 in Peru [europepmc]
Related